Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.
about
Prucalopride for the treatment of chronic constipationEffects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipationPatient considerations in the management of chronic constipation: focus on prucaloprideEffects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trialUse of Prucalopride for Chronic Constipation: A Systematic Review and Meta-analysis of Published Randomized, Controlled TrialsBrain imaging approaches to the study of functional GI disorders: a Rome working team report.Prucalopride: the evidence for its use in the treatment of chronic constipation.Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people.Prucalopride for constipation.Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipationSystematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersRandomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 studyReview article: the therapy of constipation.Bloating and functional gastro-intestinal disorders: where are we and where are we going?Review article: the pharmacological treatment of acute colonic pseudo-obstruction.Serotonergic modulation of visceral sensation: lower gut.Serotonergic modulating drugs for functional gastrointestinal diseases.Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation.Role of serotonin in the pathophysiology of the irritable bowel syndrome.New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket.Novel therapies in the treatment of irritable bowel syndrome.Diagnosis and treatment of chronic constipation--a European perspective.Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans.Pharmacology of serotonin: what a clinician should know.Prucalopride: safety, efficacy and potential applications.Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study.Prucalopride for the treatment of ileus.Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.Drug development for the irritable bowel syndrome: current challenges and future perspectivesChallenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.Prucalopride: a new drug for the treatment of chronic constipation.Prucalopride reduces the number of reflux episodes and improves subjective symptoms in gastroesophageal reflux disease: a case seriesPromotility Action of the Probiotic Bifidobacterium lactis HN019 Extract Compared with Prucalopride in Isolated Rat Large Intestine.New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.Emerging drugs for functional dyspepsia.Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.Review article: the role of gastrointestinal hormones in the treatment of delayed gastric emptying in critically ill patients.Prucalopride: a review of its use in the management of chronic constipation.
P2860
Q24203815-0B906B94-EE91-45BB-82E1-B577492F8488Q24607588-05269F0A-C23F-4C5F-8704-867484208355Q26741304-98B1D371-A1F3-4648-93E4-94164F818F67Q28364173-D2FEF686-B949-4724-A07C-0AD1CB019915Q33467828-46394C46-7E7A-43EC-A9ED-E9CE7090E14CQ33489013-51A1141D-5957-4AB6-83CA-82E3DF0BDD6DQ33973983-1B7E73EF-6F47-4592-A9A5-6DB8C8659D0FQ34030234-4D0DB6B9-A087-4860-853A-17EAAA2322B0Q34094831-5096562B-635A-4A55-AAEA-C915F1F6A13AQ34146166-E21958A8-FD0A-4EC7-B6B8-47F04E049684Q34166903-DBCE1DCF-87C7-4D25-9726-888FDBE32A5DQ34230555-1F1E9EEF-76C0-458F-8F5A-E0F9A898C774Q34266216-C2C6B6F6-A048-4C40-A107-D54B8AE9D694Q34366956-F1630B4F-5F28-479C-A279-5A87F1055868Q34421482-E057D46B-999F-490A-8F8E-3D4F5E5AB086Q34699859-1F866B20-D5D5-480C-B62E-B9526BC987E0Q34722737-19F879AF-7699-4C15-BB03-9E233707367EQ34786704-3C6F64DF-D551-4DC9-981A-BDA53661188CQ35026383-E24DD8DE-4962-4627-B886-DC2ADC1554FDQ35047066-7794E1B4-DCF6-4C65-B8EB-DF27C8DE7004Q35047707-41362304-5582-4152-9847-BE3548B282C8Q35094684-AA0CD512-0318-45C1-A50B-E04A9122782AQ35207439-2A5C3063-4EC6-409E-8E65-A3C82BF6F5A6Q35361939-BC485292-9D19-4E6F-8330-9D93CD75714AQ35596862-6D409057-223C-4733-8CAD-28779F02389CQ35688594-05CDFFEA-6A7C-4624-8D03-1A3FAB98D62BQ35718568-FE65F382-451C-48B7-8638-F4DBE1359381Q36302121-81153F6D-FA93-479F-9558-1045B80D3B0DQ36431809-94B15109-55B6-43D4-A817-D53A108C6166Q36579818-F836D45A-CA64-4754-A5BD-B737B892FC7CQ37164063-A057867F-3148-4D81-8134-6C0787BEC541Q37231016-518A4CBE-3221-4453-8F48-B9079C7131E1Q37578493-5189EAE4-77A0-4898-85F1-C552D88A9C15Q37582356-C47B859F-ED44-410C-BC3C-BA4C131DE464Q37607208-F4C9BF2D-2956-4614-92E7-72C6C9D71867Q37735172-11688678-98F7-43EF-B6FE-BC132EB4AA92Q37854060-327E5AD4-18D1-4187-A150-0CEFA146ECF4Q38044067-EDFC2D78-68C5-4EC6-B0FB-2874FA5C8C16Q38123557-EBA3260F-26AB-4D1E-8162-F666313AD17EQ38160205-071FE5B6-E4FB-4BA3-A818-D79A9EC52427
P2860
Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Selective stimulation of colon ...... ucalopride, in healthy humans.
@ast
Selective stimulation of colon ...... ucalopride, in healthy humans.
@en
type
label
Selective stimulation of colon ...... ucalopride, in healthy humans.
@ast
Selective stimulation of colon ...... ucalopride, in healthy humans.
@en
prefLabel
Selective stimulation of colon ...... ucalopride, in healthy humans.
@ast
Selective stimulation of colon ...... ucalopride, in healthy humans.
@en
P2093
P2860
P356
P1433
P1476
Selective stimulation of colon ...... ucalopride, in healthy humans.
@en
P2093
D D Burton
E P Bouras
M Camilleri
S McKinzie
P2860
P304
P356
10.1136/GUT.44.5.682
P407
P577
1999-05-01T00:00:00Z